8 research outputs found

    IL15RA Drives Antagonistic Mechanisms of Cancer Development and Immune Control in Lymphocyte-Enriched Triple-Negative Breast Cancers

    No full text
    Abstract Despite its aggressive nature, triple-negative breast cancer (TNBC) often exhibits leucocyte infiltrations that correlate with favorable prognosis. In this study, we offer an explanation for this apparent conundrum by defining TNBC cell subsets that overexpress the IL15 immune receptor IL15RA. This receptor usually forms a heterotrimer with the IL2 receptors IL2RB and IL2RG, which regulates the proliferation and differentiation of cytotoxic T cells and NK cells. However, unlike IL15RA, the IL2RB and IL2RG receptors are not upregulated in basal-like TNBC breast cancer cells that express IL15RA. Mechanistic investigations indicated that IL15RA signaling activated JAK1, STAT1, STAT2, AKT, PRAS40, and ERK1/2 in the absence of IL2RB and IL2RG, whereas neither STAT5 nor JAK2 were activated. RNAi-mediated attenuation of IL15RA established its role in cell growth, apoptosis, and migration, whereas expression of the IL15 cytokine in IL15RA-expressing cells stimulated an autocrine signaling cascade that promoted cell proliferation and migration and blocked apoptosis. Notably, coexpression of IL15RA and IL15 was also sufficient to activate peripheral blood mononuclear cells upon coculture in a paracrine signaling manner. Overall, our findings offer a mechanistic explanation for the paradoxical association of some high-grade breast tumors with better survival outcomes, due to engagement of the immune stroma. Cancer Res; 74(17); 4908ā€“21. Ā©2014 AACR.</jats:p

    Low-Density Lipoprotein Uptake Inhibits the Activation and Antitumor Functions of Human VĪ³9VĪ“2 T Cells

    No full text
    Abstract VĪ³9VĪ“2 T cells, the main subset of Ī³Ī“ T lymphocytes in human peripheral blood, are endowed with antitumor functions such as cytotoxicity and IFNĪ³ production. These functions are triggered upon T-cell receptorā€“dependent activation by non-peptidic prenyl pyrophosphates (ā€œphosphoantigensā€) that are selective agonists of VĪ³9VĪ“2 T cells, and which have been evaluated in clinical studies. Because phosphoantigens have shown interindividual variation in VĪ³9VĪ“2 T-cell activities, we asked whether metabolic resources, namely lipids such as cholesterol, could affect phosphoantigen-mediated VĪ³9VĪ“2 T-cell activation and function. We show here that VĪ³9VĪ“2 T cells express the LDL receptor upon activation and take up LDL cholesterol. Resulting changes, such as decreased mitochondrial mass and reduced ATP production, correlate with downregulation of VĪ³9VĪ“2 T-cell activation and functionality. In particular, the expression of IFNĪ³, NKG2D, and DNAM-1 were reduced upon LDL cholesterol treatment of phosphoantigen-expanded VĪ³9VĪ“2 T cells. As a result, their capacity to target breast cancer cells was compromised both in vitro and in an in vivo xenograft mouse model. Thus, this study describes the role of LDL cholesterol as an inhibitor of the antitumor functions of phosphoantigen-activated VĪ³9VĪ“2 T cells. Our observations have implications for therapeutic applications dependent on VĪ³9VĪ“2 T cells. Cancer Immunol Res; 6(4); 448ā€“57. Ā©2018 AACR.</jats:p

    Expression of c-kit and Sca-1 and their relationship with multidrug resistance protein 1 in mouse bone marrow mononuclear cells

    No full text
    P-glycoprotein (Pgp) and multidrug resistance protein 1 (MRP1) are members of the ATP-binding cassette (ABC) family of transporter proteins. Both molecules are membrane-associated, energy-dependent efflux pumps with different substrate selectivity and they may play a role in the activation, differentiation and function of haematopoietic cells. Mouse haematopoietic cells are characterized by the expression of the cell surface molecules c-kit and Sca-1. Herein, the presence and activities of Pgp and MRP1 in mouse bone marrow mononuclear cells (BMMC) and their relationship with the proteins c-kit and Sca-1 were evaluated. Pgp and MRP activities were measured based on the extrusion of rhodamine 123 (for Pgp) and Fluo-3 (for MRP). Cell populations were assessed by cytometry using anti-c-kit and anti-Sca1 antibodies. Pgp activity was present in 5% of BMMC while 50% of BMMC cells showed MRP activity. These findings agreed with the proportion of cells expressing the MRP1 surface molecule (51Ā·3 Ā± 4Ā·17%). About 14% of BMMC were positive for c-kit and/or Sca-1 (9Ā·3% c-kitā€“ Sca-1+, 4Ā·2% c-kit+ Sca-1ā€“ and 0Ā·9% c-kit+ Sca-1+). Among these subpopulations only c-kitā€“ Sca-1+ cells presented Pgp activity (21Ā·36%). On the other hand, MRP activity was present in all three subpopulations. Most cells (82Ā·5%) of the c-kit+ Sca-1ā€“ subpopulation presented MRP1 activity compared to only 54Ā·1% of c-kit+ Sca-1+ and 38Ā·8% of c-kitā€“ Sca-1+. This study demonstrates the expression and activity of MRP1 in BMMC. While only a small proportion of precursor cells had Pgp activity, MRP1 activity was present among different subpopulations of precursor cells. Further studies are necessary to establish the role of these transporters in haematopoietic cells

    Global patterns of antigen receptor repertoire disruption across adaptive immune compartments in COVID-19

    Get PDF
    Whereas pathogen-specific T and B cells are a primary focus of interest during infectious disease, we have used COVID-19 to ask whether their emergence comes at a cost of broader B cell and T cell repertoire disruption. We applied a genomic DNA-based approach to concurrently study the immunoglobulin-heavy (IGH) and T cell receptor (TCR) Ī² and Ī“ chain loci of 95 individuals. Our approach detected anticipated repertoire focusing for the IGH repertoire, including expansions of clusters of related sequences temporally aligned with SARS-CoV-2ā€“specific seroconversion, and enrichment of some shared SARS-CoV-2ā€“associated sequences. No significant age-related or disease severityā€“related deficiencies were noted for the IGH repertoire. By contrast, whereas focusing occurred at the TCRĪ² and TCRĪ“ loci, including some TCRĪ² sequenceā€“sharing, disruptive repertoire narrowing was almost entirely limited to many patients aged older than 50 y. By temporarily reducing T cell diversity and by risking expansions of nonbeneficial T cells, these traits may constitute an age-related risk factor for COVID-19, including a vulnerability to new variants for which T cells may provide key protection
    corecore